About
Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden.
Annual results
Reported figures, SEK
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | — | -34.0M | — | — |
| 2024 | — | -39.0M | — | — |
| 2023 | — | -128M | — | — |
| 2022 | 1.0M | -367M | -36700.0% | — |
| 2021 | 26.0M | -138M | -530.8% | — |
VIVE.ST in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Vivesto AB are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.